mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |